Clinical Correlates and Outcomes of Dual Basiliximab and Antithymocyte Globulin Induction in Kidney Transplant Recipients: A National Study

Clinical Correlates and Outcomes of Dual Basiliximab and Antithymocyte Globulin Induction in Kidney Transplant Recipients: A National Study

Background. The unplanned use of dual induction therapy with interleukin-2 receptor-blocking antibodies (IL2rAb) and antithymocyte globulin (ATG) may portend adverse outcomes. Methods. We used national transplant registry data to study clinical correlates and outcomes of single versus dual induction...

Full description

Bibliographic Details
Main Authors: Ngan N. Lam, MD, Rachel Jeong, MD, Robert R. Quinn, MD, PhD, Pietro Ravani, MD, PhD, Huiling Xiao, MS, Mara McAdams-DeMarco, PhD, David A. Axelrod, MD, MBA, Mark A. Schnitzler, PhD, Jon J. Snyder, PhD, Krista L. Lentine, MD, PhD
Format: Article
Language:English
Published: Wolters Kluwer 2021-08-01
Series:Transplantation Direct
Online Access:http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001190

Internet

http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001190

Similar Items